Expression of Expanded CAG Transcripts Triggers Nucleolar Stress in Huntington's Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cerebellum

• Publication date

  2013-01-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12311-012-0447-6PMID 23315009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CAG expansion induces nucleolar stress in polyglutamine diseases

  2012cited by this paper
• A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity

  2012cited by this paper
• Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease

  2011influential reference
• Epigenetic Silencing of Nucleolar rRNA Genes in Alzheimer's Disease

  2011cited by this paper
• Huntington's disease: a clinical review

  2010cited by this paper
• Transcription-independent p53 apoptosis: an alternative route to death.

  2010cited by this paper
• Signaling to p53: ribosomal proteins find their way.

  2009cited by this paper
• Activation of an Endogenous Suicide Response after Perturbation of rRNA Synthesis Leads to Neurodegeneration in Mice

  2008cited by this paper
• RNA toxicity is a component of ataxin-3 degeneration in Drosophila

  2008cited by this paper
• Human Genome & Diseases: Review Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies

  2006cited by this paper
• Epigenetic Mechanism of rRNA Gene Silencing: Temporal Order of NoRC-Mediated Histone Modification, Chromatin Remodeling, and DNA Methylation

  2005cited by this paper
• Huntingtin and the molecular pathogenesis of Huntington's disease

  2004cited by this paper
• Dyskeratosis Congenita and Cancer in Mice Deficient in Ribosomal RNA Modification

  2003cited by this paper
• Does the ribosome translate cancer?

  2003cited by this paper

• Transcriptome Study in Sicilian Patients with Huntington’s Disease

  2025cites this paper
• Nucleolar aggregation of key neuropathological proteins in the postmortem neurodegenerative brain

  2025cites this paper
• NMR structures and magnetic force spectroscopy studies of small molecules binding to models of an RNA CAG repeat expansion

  2024cites this paper
• Unraveling the Puzzle of Therapeutic Peptides: A Promising Frontier in Huntington's Disease Treatment.

  2024cites this paper
• Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases

  2024cites this paper
• The molecular mechanisms of spinocerebellar ataxias for DNA repeat expansion in disease.

  2023cites this paper
• Molecular insights into the interaction of CAG trinucleotide RNA repeats with nucleolin and its implication in polyglutamine diseases

  2022cites this paper
• RNA Helicases in Microsatellite Repeat Expansion Disorders and Neurodegeneration

  2022cites this paper
• The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference

  2022cites this paper
• Interaction of huntingtin (HTT) with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.

  2021cites this paper
• Mechanisms of repeat-associated non-AUG translation in neurological microsatellite expansion disorders

  2021cites this paper
• Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression

  2021cites this paper
• Whole exome sequencing identifies genes associated with Tourette’s Disorder in multiplex families

  2021influential citation
• Challenges in RNA Regulation in Huntington's Disease: Insights from Computational Studies

  2020cites this paper
• Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries

  2020cites this paper
• Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases.

  2020cites this paper
• A Peptidylic Inhibitor for Neutralizing r(GGGGCC)exp-Associated Neurodegeneration in C9ALS-FTD

  2019cites this paper
• The nucleolus: a central response hub for the stressors that drive cancer progression

  2019cites this paper
• Understanding the Pathogenicity of Noncoding RNA Expansion-Associated Neurodegenerative Disorders

  2019cites this paper
• rRNA and tRNA Bridges to Neuronal Homeostasis in Health and Disease.

  2019cites this paper
• Integration of the Deacetylase SIRT1 in the Response to Nucleolar Stress: Metabolic Implications for Neurodegenerative Diseases

  2019cites this paper
• Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington’s Disease

  2018cites this paper
• Current state of brain stroke problem in the West Kazakhstan Region

  2018cites this paper
• Alteration of rRNA gene copy number and expression in patients with intellectual disability and heteromorphic acrocentric chromosomes

  2018cites this paper
• Evaluation of therapeutic targets for the treatment of behavioral alterations and neuropathology in Huntington’s disease. The role of histone deacetylase 3 and p75 neurotrophin receptor

  2018cites this paper
• A recurrent de novo missense mutation in UBTF causes developmental neuroregression

  2018cites this paper
• A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases

  2018cites this paper
• Ultrastructural Localization and Molecular Associations of HCV Capsid Protein in Jurkat T Cells

  2018cites this paper
• A recurrent de novo missense mutation in UBTF causes developmental neuroregression

  2018cites this paper
• Translating Antisense Technology into a Treatment for Huntington's Disease.

  2018cites this paper
• Spinocerebellar ataxias: prospects and challenges for therapy development

  2018cites this paper
• Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration.

  2018cites this paper
• Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions

  2017cites this paper
• Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats.

  2017cites this paper
• Mechanisms of inclusion assembly in Huntington’s disease

  2017cites this paper
• New perspectives of physiological and pathological functions of nucleolin (NCL)

  2017cites this paper
• Cytomegalovirus Late Protein pUL31 Alters Pre-rRNA Expression and Nuclear Organization during Infection

  2017cites this paper
• A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases

  2017cites this paper
• Requirement of Neuronal Ribosome Synthesis for Growth and Maintenance of the Dendritic Tree*

  2016cites this paper
• COLLECTION : TRANSLATIONAL IMPACT OF DROSOPHILA Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA-and protein-mediated toxicities in patient cells and Drosophila

  2016influential citation
• p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases

  2016cites this paper
• Proapoptotic Requirement of Ribosomal Protein L11 in Ribosomal Stress-Challenged Cortical Neurons

  2016cites this paper
• RNA toxicity induced by expanded CAG repeats in Huntington's disease

  2016cites this paper
• Identifying proteins that bind to specific RNAs - focus on simple repeat expansion diseases

  2016cites this paper
• Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.

  2016cites this paper
• The 5’-Untranslated Region of the C9orf72 mRNA Exhibits a Phylogenetic Alignment to the Cis-Aconitase Iron-Responsive Element; Novel Therapies for Amytrophic Lateral Sclerosis

  2016cites this paper
• Regulation of mRNA Translation by MID1: A Common Mechanism of Expanded CAG Repeat RNAs

  2016cites this paper
• Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.

  2016cites this paper
• A peptidylic inhibitor-based therapeutic approach that simultaneously suppresses RNA-and protein-mediated toxicities in polyglutamine diseases

  2016cites this paper
• Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status*

  2016cites this paper
• Role of the nucleolus in neurodegenerative diseases with particular reference to the retina: a review

  2016cites this paper
• The role of the nucleolus in neurodegeneration.

  2016cites this paper
• RNA-Binding Proteins in the Regulation of miRNA Activity: A Focus on Neuronal Functions

  2015cites this paper
• Role of nucleolar dysfunction in neurodegenerative disorders: a game of genes?

  2015cites this paper
• Structural Insights Reveal the Dynamics of the Repeating r(CAG) Transcript Found in Huntington’s Disease (HD) and Spinocerebellar Ataxias (SCAs)

  2015cites this paper
• Insights into the regulation of neuronal viability by nucleophosmin/B23

  2015cites this paper
• Role of sirtuin 3 on mitochondrial dynamics in Huntington's disease striatal cells

  2015cites this paper
• Invited Review: Decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art

  2015cites this paper
• Non-coding RNA in neural function, disease, and aging

  2015cites this paper
• Roles of the nucleolus in the CAG RNA-mediated toxicity.

  2014cites this paper
• Nucleolar stress with and without p53

  2014cites this paper
• How Parkinson's disease meets nucleolar stress.

  2014cites this paper
• Antibodies and protein misfolding: From structural research tools to therapeutic strategies.

  2014cites this paper
• RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders

  2014cites this paper
• RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis

  2014cites this paper
• Mechanisms of RNA-induced toxicity in CAG repeat disorders

  2013cites this paper
• Overexpression of Ribosomal GenesSuppress Poly-Q (Glutamine)Induced Toxicity of Human Huntington’s Disease Protein in Yeast

  2013cites this paper